G Brufman

4.4k total citations · 1 hit paper
38 papers, 1.9k citations indexed

About

G Brufman is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, G Brufman has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in G Brufman's work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (8 papers) and Medical Imaging and Pathology Studies (4 papers). G Brufman is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (8 papers) and Medical Imaging and Pathology Studies (4 papers). G Brufman collaborates with scholars based in Israel, United States and Switzerland. G Brufman's co-authors include Rut Isacson, J Pater, Richard M. Hansen, Philippe Rougier, Jean‐Pierre Pignon, Cynthia G. Leichman, Brian Weinerman, J. Fryer, Benny Zee and A. Laplanche and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

In The Last Decade

G Brufman

37 papers receiving 1.8k citations

Hit Papers

Efficacy of intravenous continuous infusion of fluorourac... 1998 2026 2007 2016 1998 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.
    1998 789 citations Philippe Rougier, Marc Buyse et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Brufman Israel 11 1.3k 445 348 244 209 38 1.9k
Rut Isacson Israel 10 1.3k 1.0× 441 1.0× 340 1.0× 378 1.5× 205 1.0× 22 1.9k
Massimo Lopez Italy 21 1.6k 1.2× 598 1.3× 282 0.8× 405 1.7× 274 1.3× 59 2.2k
J J Lokich United States 5 1.4k 1.0× 486 1.1× 363 1.0× 163 0.7× 230 1.1× 6 1.6k
M Forni France 19 1.1k 0.8× 458 1.0× 299 0.9× 526 2.2× 70 0.3× 39 1.8k
A. Taamma France 14 1.1k 0.8× 867 1.9× 354 1.0× 321 1.3× 85 0.4× 19 1.8k
Fred J. Ansfield United States 24 1.0k 0.8× 476 1.1× 418 1.2× 367 1.5× 178 0.9× 52 1.8k
P Soulié France 25 1.7k 1.2× 761 1.7× 239 0.7× 369 1.5× 225 1.1× 118 2.3k
Nikolaos Ziras Greece 17 996 0.7× 369 0.8× 207 0.6× 150 0.6× 181 0.9× 55 1.2k
John F. Hannigan United States 18 713 0.5× 552 1.2× 638 1.8× 200 0.8× 334 1.6× 30 1.9k
Νicolas Tsavaris Greece 22 999 0.7× 495 1.1× 304 0.9× 259 1.1× 52 0.2× 87 1.7k

Countries citing papers authored by G Brufman

Since Specialization
Citations

This map shows the geographic impact of G Brufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Brufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Brufman more than expected).

Fields of papers citing papers by G Brufman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Brufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Brufman. The network helps show where G Brufman may publish in the future.

Co-authorship network of co-authors of G Brufman

This figure shows the co-authorship network connecting the top 25 collaborators of G Brufman. A scholar is included among the top collaborators of G Brufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Brufman. G Brufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ron, Ilan G., Nely Wigler, Riva Borovik, et al.. (2001). CMF (Cyclophosphamide, Methotrexate, 5-Fluorouracil) Versus CNF (Cyclophosphamide, Mitoxantrone, 5-Fluorouracil) as Adjuvant Chemotherapy for Stage II Lymph-Node Positive Breast Cancer. American Journal of Clinical Oncology. 24(4). 323–327. 7 indexed citations
2.
Lyass, Olga, Beatrice Uziely, Rami Ben‐Yosef, et al.. (2000). Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer. 89(5). 1037–1047. 323 indexed citations
3.
Rougier, Philippe, Marc Buyse, Jean‐Pierre Pignon, et al.. (1998). Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer.. Journal of Clinical Oncology. 16(1). 301–308. 789 indexed citations breakdown →
4.
5.
Brufman, G, et al.. (1995). 1234 Can zinc picolinate in patients receiving chemotherapy for metastatic colorectal carcinoma prevent stomatitis?. European Journal of Cancer. 31. S258–S258. 2 indexed citations
6.
Brufman, G, et al.. (1994). Megestrol Acetate in Advanced Breast Carcinoma after Failure to Tamoxifen and/or Aminoglutethimide. Oncology. 51(3). 258–261. 12 indexed citations
7.
Brufman, G, Nissim Haim, Noa Ben-Baruch, & Aarón Sulkes. (1993). Second-Line Chemotherapy with Mitoxantrone as a Single Agent in Metastatic Breast Cancer. Journal of Chemotherapy. 5(1). 43–46. 11 indexed citations
8.
Uziely, Beatrice, et al.. (1993). The effect of tamoxifen on the endometrium. Breast Cancer Research and Treatment. 26(1). 101–105. 78 indexed citations
9.
10.
Brufman, G, et al.. (1991). Fetal Hemoglobin Screening in Whole Blood and in Plasma of Cancer Patients. Tumor Biology. 12(1). 45–51. 5 indexed citations
11.
Brufman, G & S Biran. (1990). Second Line Hormonal Therapy with Aminoglutethimide in Metastatic Breast Cancer. Acta Oncologica. 29(6). 717–720. 7 indexed citations
12.
13.
Brufman, G, et al.. (1989). Methylprednisolone and Chlorpromazine in Patients Receiving Cancer Chemotherapy: A prospective non-randomized study. Journal of Chemotherapy. 1(2). 140–143. 3 indexed citations
14.
Sulkes, Aarón, Beatrice Uziely, Rut Isacson, G Brufman, & S Biran. (1989). Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.. PubMed. 24(9-10). 604–10. 1 indexed citations
15.
Brufman, G, et al.. (1988). Evaluation of Fetal Hemoglobin in Various Malignancies with Reference to the Patients’ Age. Tumor Biology. 9(2-3). 95–100. 4 indexed citations
16.
Brufman, G & S Biran. (1986). Aminoglutethimide as second line endocrine therapy in advanced breast cancer.. PubMed. 6(5). 1065–8. 2 indexed citations
17.
Rizel, Shulamith, S Biran, S.O. Anteby, et al.. (1985). Combined modality treatment for stage III ovarian carcinoma. Radiotherapy and Oncology. 3(3). 237–244. 17 indexed citations
18.
Sulitzeanu, D., et al.. (1982). Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assay.. PubMed. 17(9-10). 869–73. 1 indexed citations
19.
Brufman, G, et al.. (1977). [Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix].. PubMed. 92(8). 349–50. 13 indexed citations
20.
Biran, S, B Bercovici, & G Brufman. (1977). Paraneoplastic hypercalcemic syndrome associated with ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 7(4). 239–242. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rut Isacson Breakdown of academic impact, for papers by Massimo Lopez Breakdown of academic impact, for papers by J J Lokich Breakdown of academic impact, for papers by M Forni Breakdown of academic impact, for papers by A. Taamma Breakdown of academic impact, for papers by Fred J. Ansfield Breakdown of academic impact, for papers by P Soulié Breakdown of academic impact, for papers by Nikolaos Ziras Breakdown of academic impact, for papers by John F. Hannigan Breakdown of academic impact, for papers by Νicolas Tsavaris
Rankless by CCL
2026